Arginine vasopressin to manage hypoxemic infants after stage i palliation of single ventricle lesions

Pediatric Critical Care Medicine

Volumn 9, Issue 5, 2008, Pages 506-510

  Mastropietro, Christopher W ^a   Clark, Jeff A ^a   Delius, Ralph E ^a   Walters, Henry L ^a   Sarnaik, Ashok P ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Qp Qs; Single ventricle; Vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; CARBON DIOXIDE; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; LACTIC ACID; MILRINONE; NITRIC OXIDE; OXYGEN; VASOCONSTRICTOR AGENT;

ARTERIAL GAS; ARTERIAL PH; ARTICLE; ATELECTASIS; BLALOCK TAUSSIG SHUNT; BLOOD PRESSURE; CARBON DIOXIDE TENSION; CASE REPORT; CHILD; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; EBSTEIN ANOMALY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART RATE; HEART SINGLE VENTRICLE; HEMATOCRIT; HEMODYNAMICS; HUMAN; HYPOXEMIA; INOTROPISM; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; LACTATE BLOOD LEVEL; LOW DRUG DOSE; LUNG BLOOD FLOW; MEDICAL RECORD REVIEW; NORWOOD PROCEDURE; OSCILLATION; OXYGEN SATURATION; OXYGEN TENSION; PALLIATIVE THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULSE OXIMETRY; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SYSTEMIC CIRCULATION; TEACHING HOSPITAL; TERTIARY HEALTH CARE; URINE VOLUME; VASCULAR RESISTANCE; ANOXIA; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MEDICAL AUDIT; NEWBORN; PATHOPHYSIOLOGY;

ANOXIA; ARGININE VASOPRESSIN; EBSTEIN ANOMALY; FEMALE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT, NEWBORN; MEDICAL AUDIT; PALLIATIVE CARE; RETROSPECTIVE STUDIES; VASOCONSTRICTOR AGENTS;

EID: 60849131273     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181849ce0     Document Type: Article

References (19)

1. Landry DW: Vasopressin deficiency and hypersensitivity in vasodilatory shock: Discovery of a new clinical syndrome. P&S Med Rev 1996; 3:3-4
2. Argenziano M, Choudri AF, Oz MC, et al: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(Suppl II): 286-290
3. Argenziano M, Chen JM, Cullinane S, et al: A prospective randomized trial of arginine va-sopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant 1999; 18:814-817
4. Morales Dl, Gregg D, Helman DN, et al: Ar-ginine vasopressin in the treatment of post-cardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69:102-106
5. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin concentrations in septic shock. Crit Care Med 2003; 31: 1752-1758
6. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
7. Rosenzweig EB, Starc TJ, Chen JM, et al: Intravenous arginine vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100: II182-II186
8. Lechner E, Hofer A, Mair R, et al: Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr 2007; 166:1221-1227
9. Marino BS, Wernovsky G, Greeley WJ: Single-ventricle lesions. In: Critical Heart Disease in Infants and Children. Second Edition. Nichols DG II (Ed). Philadelphia, PA, Mosby Elsevier, 2006, pp 789-797
10. Wernovsky G, Wypij D, Jonas RA, et al: Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235
11. Wessel DL, Adatia I, Giglia TM, et al: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial dysfunction after cardiopulmonary bypass. Circulation 1993; 88:2128-2138
12. Barrett LK, Singer M, Clapp LH: Vasopressin: Mechanisms of action on the vascular in health and in septic shock. Crit Care Med 2007; 35:33-40
13. Cheung PY, Barrington KJ, Pearson RJ, et al: Systemic, pulmonary, and mesenteric perfusion and oxygenation effects of dopamine and epinephrine. Am J Respir Crit Care Med 1997; 155:32-37
14. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al: Alpha-adrenoceptor stimulation of porcine pulmonary arteries. Eur J Pharma-col 1993; 235:169-175
15. Walker BR, Haynes J Jr, Wang HL, et al: Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol 1989; 257:H415-H422
16. Evora PR, Pearson PJ, Schaff HV: Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 1993; 103:1241-1245
17. Thibonnier M, Conarty DM, Preston JA, et al: Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999; 140:1301-1309
18. Walker BR, Childs ME, Adams EM: Direct cardiac effects of vasopressin: Role of V1- and V2-vasopressinergic receptors. Am J Physiol 1988; 255:H261-H265
19. Kent AL, Kecskes Z, Shadbolt B, et al: Blood pressure in the first year of life in healthy infants born at term. Pediatr Nephrol 2007; 22:1743-1749